These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 10075741)

  • 21. Optimal lysophosphatidic acid-induced DNA synthesis and cell migration but not survival require intact autophosphorylation sites of the epidermal growth factor receptor.
    Deng W; Poppleton H; Yasuda S; Makarova N; Shinozuka Y; Wang DA; Johnson LR; Patel TB; Tigyi G
    J Biol Chem; 2004 Nov; 279(46):47871-80. PubMed ID: 15364923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha.
    Stover DR; Becker M; Liebetanz J; Lydon NB
    J Biol Chem; 1995 Jun; 270(26):15591-7. PubMed ID: 7797556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene.
    Wasilenko WJ; Payne DM; Fitzgerald DL; Weber MJ
    Mol Cell Biol; 1991 Jan; 11(1):309-21. PubMed ID: 1702513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.
    Demory ML; Boerner JL; Davidson R; Faust W; Miyake T; Lee I; Hüttemann M; Douglas R; Haddad G; Parsons SJ
    J Biol Chem; 2009 Dec; 284(52):36592-36604. PubMed ID: 19840943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
    Seta K; Sadoshima J
    J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion.
    Harder KW; Moller NP; Peacock JW; Jirik FR
    J Biol Chem; 1998 Nov; 273(48):31890-900. PubMed ID: 9822658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
    Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
    J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.
    Nair VD; Sealfon SC
    J Biol Chem; 2003 Nov; 278(47):47053-61. PubMed ID: 12970364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
    Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
    Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
    Lee H; Woodman SE; Engelman JA; Volonté D; Galbiati F; Kaufman HL; Lublin DM; Lisanti MP
    J Biol Chem; 2001 Sep; 276(37):35150-8. PubMed ID: 11451957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
    Fan YX; Wong L; Johnson GR
    Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
    Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of epidermal growth factor receptor sequences as E. coli fusion proteins: applications in the study of tyrosine kinase function.
    Koland JG; O'Brien KM; Cerione RA
    Biochem Biophys Res Commun; 1990 Jan; 166(1):90-100. PubMed ID: 2154210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes.
    Glasgow WC; Hui R; Everhart AL; Jayawickreme SP; Angerman-Stewart J; Han BB; Eling TE
    J Biol Chem; 1997 Aug; 272(31):19269-76. PubMed ID: 9235921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
    Miller WE; Maudsley S; Ahn S; Khan KD; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2000 Apr; 275(15):11312-9. PubMed ID: 10753943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.